Session

The lazy and the lively bladder

Poster Session 78

  • Location:
    Room 14a (ICM, Level 1)
  • Chairs:
     F. Bagheri, Dubai (AE)
     K. Monastyrskaya, Berne (CH)
     T. Tarcan, Istanbul (TR)
  • Aims and objectives of this session

    Overview of new developments in the under- and overactive detrusor

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
986
The histopathologic and pharmacodynamic effects of intradetrusor decorin injection for partial bladder outlet obstruction model of rabbits

By: Kaya E.1, Kibar Y.1, Yılmaz S.1, Ebiloglu T.2, Ozcan A.3, Seyrek M.4, Yıldız O.4

Institutes: 1Gulhane Military Medical Academy, Dept. of Urology, Ankara, Turkey, 2Etimesgut Military Hospital, Dept. of Urology, Ankara, Turkey, 3Gulhane Military Medical Academy, Dept. of Pathology, Ankara, Turkey, 4Gulhane Military Medical Academy, Dept. of Medical Pharmacology, Ankara, Turkey

987
Association between free flow and bladder outlet obstruction index and bladder contractility index

By: Abdelmoteleb H., Hashim H.

Institutes: Bristol Urological Institute, Dept. of Urology, Bristol, United Kingdom

988
Defining urodynamic bladder outlet obstruction (BOO) and detrusor underactivity (DU), with a novel common for both genders nomogram

By: Mytilekas K., Ioannidou E., Kalaitzi M., Georgopoulos P., Ioannidis E., Apostolidis A.

Institutes: Aristetles University Thessalonikis, Dept. of Urology, Thessaloniki, Greece

989
A novel non-invasive test for the evaluation of detrusor muscle reserve in young adult males to overcome outflow resistance

By: Abdelmoula A.2, Shoukry M.S.1, Hassouna M.1, Eid A.1

Institutes: 1University of Alexandria, Dept. of Urology, Alexandria, Egypt, 2University of Tripoli, Dept. of Urology, Tripoli, Libya

990
International Continence Society definition of detrusor underactivity; analysis of clinical parameters and comparison with contractility grading methods

By: Ten Donkelaar C.S., Rosier P.F.W.M., De Kort L.M.O.

Institutes: University Medical Center Utrecht, Dept. of Urology, Utrecht, The Netherlands

991
Using the degree of bladder outlet obstruction to predict bladder contractility in men

By: Abrams P.1, Gammie A.1, Kaper M.2, Dorrepaal C.2, Kos T.2

Institutes: 1Bristol Urological Institute, Dept. of Urodynamics, Bristol, United Kingdom, 2Astellas Pharma Europe B.V., Therapeutic Area Urology, Leiden, The Netherlands

992
Glycemic control is associated with the prevalence of overactive bladder (OAB) and lower urinary tract symptoms (LUTS) but also with the management of LUTS in diabetic patients: A controlled study

By: Tsilioni A.2, Tsanikidis H.2, Georgopoulos P.1, Kazakos K.3, Apostolidis A.1

Institutes: 1Aristotle University of Thessaloniki, Dept. of Urology, Thessaloniki, Greece, 2General Hospital of Katerini, Dept. of Internal Medicine, Katerini, Greece, 3Alexandreion Technological Insitute, Dept. Nursing, Thessaloniki, Greece

993
Role of phosphodiesterase 5 inhibitors in the treatment of over-active bladder in older patients

By: Dell’Atti L., Ughi G., Capparelli G., Papa S., Fornasari L., Ippolito C.

Institutes: University Hospital “St. Anna”, Dept. of Urology, Ferrara, Italy

994
Inhibition of smooth muscle contraction by the inhibitor for cytohesin familiy guanosine nucleotide exchange factors, secin H3 in the hyperplastic human prostate

By: Hennenberg M., Keller P., Schott M., Tamalunas A., Ciotkowska A., Rutz B., Waidelich R., Strittmatter F., Stief C., Gratzke C.

Institutes: LMU Munich, Dept. of Urology, Munich, Germany

995
The patient experience of underactive bladder

By: Uren A.1, Cotterill N.1, Harding C.2, Hillary C.3, Chapple C.3, Klaver M.4, Bongaerts D.4, Hakimi Z.4, Abrams P.1

Institutes: 1Bristol Urological Institute, Southmead Hospital, Bristol, United Kingdom, 2Freeman Hospital, Dept. of Urology, Newcastle, United Kingdom, 3Royal Hallamshire Hospital, Dept. of Urology, Sheffield, United Kingdom, 4Astellas, Astellas Pharma B.V., Leiden, The Netherlands

996
MicroRNA biomarkers of urodynamically-defined states of bladder outlet obstruction-induced lower urinary tract dysfunction

By: Hashemi Gheinani A.1, Burkhard F.C.2, Rehrauer H.3, Aquino Fournier C.3, Keller I.3, Bruggmann R.4, Monastyrskaya K.1

Institutes: 1Urology Research Laboratory, Dept. of Clinical Research, Berne, Switzerland, 2University Hospital Berne, Dept. of Urology, Berne, Switzerland, 3Functional Genomics Center, Zurich, Switzerland, 4University of Berne, Interfaculty Bioinformatics Unit, Berne, Switzerland

997
Prediction of sacral neuromodulation treatment success in men with detrusor underactivity using a bladder outlet obstruction-contractility nomogram

By: Rademakers K.1, Drossaerts J.1, Van Kerrebroeck P.1, Oelke M.2, Van Koeveringe G.1

Institutes: 1Maastricht UMC+, Dept. of Urology, Maastricht, The Netherlands, 2Hanover Medical School, Dept. of Urology, Hanover, Germany

998
Detrusor muscle reserve, do we have a definition?

By: Abdelmoula A.2, Shoukry M.1, Hassona M.1, Abulfotooh Eid A.1

Institutes: 1University of Alexandria, Dept. of Urology, Alexandria, Egypt, 2University of Tripoli, Dept. of Urology, Tripoli, Libya

999
How many days do patients with overactive bladder (OAB) receive treatment in real clinical practice? Comparison of anti-cholinergic agents and beta3-adrenergic receptor agonist

By: Ito N, Hirobe M., Hashimoto J.

Institutes: Ntt-east Corporation Sapporo Medical Center, Dept. of Urology, Sapporo, Japan

Summary and context
 K. Monastyrskaya, Berne (CH)